Departamento de Biomateriales, Instituto de Ciencia y Tecnología de Polímeros, CSIC, 28006 Madrid, Spain.
Instituto de Física, Universidad Autónoma de San Luis Potosí, Manuel Nava 6, Zona Universitaria, San Luis Potosí C.P. 78290, S.L.P., Mexico.
Molecules. 2019 Apr 27;24(9):1660. doi: 10.3390/molecules24091660.
Nowadays, regenerative medicine has paid special attention to research (in vitro and in vivo) related to bone regeneration, specifically in the treatment of bone fractures or skeletal defects, which is rising worldwide and is continually demanding new developments in the use of stem cells, growth factors, membranes and scaffolds based on novel nanomaterials, and their applications in patients by using advanced tools from molecular biology and tissue engineering. Strontium (Sr) is an element that has been investigated in recent years for its participation in the process of remodeling and bone formation. Based on these antecedents, this is a review about the Strontium Folate (SrFO), a recently developed non-protein based bone-promoting agent with interest in medical and pharmaceutical fields due to its improved features in comparison to current therapies for bone diseases.
如今,再生医学特别关注与骨再生相关的研究(体外和体内),特别是在治疗骨折或骨骼缺陷方面,这在全球范围内不断兴起,并不断要求在基于新型纳米材料的干细胞、生长因子、膜和支架的使用方面取得新的发展,以及利用分子生物学和组织工程的先进工具将其应用于患者。锶(Sr)是近年来研究参与重塑和骨形成过程的元素。基于这些背景,本文综述了锶叶酸(SrFO),这是一种最近开发的非蛋白类促骨生长剂,由于其与目前治疗骨疾病的疗法相比具有更好的特性,因此在医学和制药领域引起了关注。